Interactions among Nrf2, NF-κB, and STAT3 signaling pathways, and their dysregulation, may play a key role in the development of cancer—including pancreatic cancer [22,43,44,45]—driven by the inflammation process. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.